243 related articles for article (PubMed ID: 31298382)
1. Inhibition effect of exosomes-mediated Let-7a on the development and metastasis of triple negative breast cancer by down-regulating the expression of c-Myc.
Du J; Fan JJ; Dong C; Li HT; Ma BL
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5301-5314. PubMed ID: 31298382
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
[TBL] [Abstract][Full Text] [Related]
3. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
[TBL] [Abstract][Full Text] [Related]
4. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.
Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W
Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835
[TBL] [Abstract][Full Text] [Related]
5. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
6. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract][Full Text] [Related]
7. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.
Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ
J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427
[TBL] [Abstract][Full Text] [Related]
9. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
[TBL] [Abstract][Full Text] [Related]
10. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
11. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
Mohammadi-Yeganeh S; Hosseini V; Paryan M
J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
[TBL] [Abstract][Full Text] [Related]
12. Yangzheng Sanjie decoction regulates proliferation and apoptosis of gastric cancer cells by enhancing let-7a expression.
Deng HX; Yu YY; Zhou AQ; Zhu JL; Luo LN; Chen WQ; Hu L; Chen GX
World J Gastroenterol; 2017 Aug; 23(30):5538-5548. PubMed ID: 28852313
[TBL] [Abstract][Full Text] [Related]
13. Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastoma.
Wang Z; Lin S; Zhang J; Xu Z; Xiang Y; Yao H; Ge L; Xie D; Kung HF; Lu G; Poon WS; Liu Q; Lin MC
Oncotarget; 2016 Aug; 7(35):56266-56278. PubMed ID: 27409345
[TBL] [Abstract][Full Text] [Related]
14. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
Wang M; Hu Y; Amatangelo MD; Stearns ME
Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
[TBL] [Abstract][Full Text] [Related]
15. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
Guo M; Zhao X; Yuan X; Jiang J; Li P
Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
[TBL] [Abstract][Full Text] [Related]
16. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc.
Liu Y; Yin B; Zhang C; Zhou L; Fan J
Biochem Biophys Res Commun; 2012 Jan; 417(1):371-5. PubMed ID: 22155254
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
20. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
